Other competencies
Specialist in hematology (FMH)
Specialist in internal medicine and hematology and oncology (D)
Additional qualification in hemostaseology (D)
Additional qualification in immunology (D)
Additional qualification in palliative medicine (D)
Additional qualification in emergency medicine (D)
Career
since 2022 Senior Attending Physician and Program Director Stem Cell Transplantation and Cellular Therapies, Department of Medical Oncology and Hematology, University Hospital Zurich
2019-2022 Attending Physician, Internal Medicine II, University Hospital Tübingen
2012-2015 Postdoctoral Fellow, Division of Blood and Marrow Transplantation, Stanford University, USA
2010-2019 Doctor in postgraduate training, Internal Medicine II, University Hospital Tübingen
2004-2010 Study of human medicine, University of Ulm
Most important memberships
Member of the Board of Directors of the USZ Transplant Center
German Society for Hematology and Medical Oncology (DGHO)
German Association for Hematopoietic Stem Cell Transplantation and Cellular Therapy (DAG-HSZT)
Research focus
– Cellular therapies
– Allogeneic stem cell transplantation
– Graft-versus-Host Disease
– Invariant natural killer T cells
– Chimeric antigen receptors
– Immune dysregulation
Publication list
https://pubmed.ncbi.nlm.nih.gov/?term=Schneidawind+D&sort=date
Further
2016 DAG-KBT Research Award of the German Working Group for Bone Marrow and Blood Stem Cell Transplantation
2015 New Investigator Award of the American Society for Blood and Marrow Transplantation
2014 Best Abstract Award for Basic Science Research of the American Society for Blood and Marrow Transplantation